APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sunitinib Generics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sunitinib Generics Industry Growth and Trends Forecast to 2032

27 December 202597 pages

Choose your research edition.

Industry ResearchSunitinib Generics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sunitinib Generics Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Sunitinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sunitinib Generics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sunitinib Generics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sunitinib Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sunitinib Generics include Aprazer Healthcare, Taj Pharma, Teva, Zydus, Hansoh Pharma, Hunan Kelun Pharmaceutical, Qilu Pharmaceutical, CSPC Pharmaceutical and Chia Tai Tianqing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sunitinib Generics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sunitinib Generics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sunitinib Generics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sunitinib Generics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sunitinib Generics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sunitinib Generics Market by Company

Aprazer Healthcare

Taj Pharma

Teva

Zydus

Hansoh Pharma

Hunan Kelun Pharmaceutical

Qilu Pharmaceutical

CSPC Pharmaceutical

Chia Tai Tianqing

Sunitinib Generics Segment by Type

50mg per Unit

37.5mg per Unit

20mg per Unit

12.5mg per Unit

Sunitinib Generics Segment by Application

Pancreatic Neuroendocrine Tumors

Gastrointestinal Stromal Tumors

Renal cell Carcinoma

Other

Sunitinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sunitinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sunitinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sunitinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sunitinib Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sunitinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg per Unit Table 2. Major Company of 37.5mg per Unit Table 3. Major Company of 20mg per Unit Table 4. Major Company of 12.5mg per Unit Table 5. Global Sunitinib Generics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 7. Global Sunitinib Generics Sales Market Share in Volume by Type (2021-2026) Table 8. Global Sunitinib Generics Sales by Type (2021-2026) & (US$ Million) Table 9. Global Sunitinib Generics Sales Market Share in Value by Type (2021-2026) Table 10. Global Sunitinib Generics Price by Type (2021-2026) & (US$/Unit) Table 11. Global Sunitinib Generics Sales by Type (2027-2032) & (K Units) Table 12. Global Sunitinib Generics Sales Market Share in Volume by Type (2027-2032) Table 13. Global Sunitinib Generics Sales by Type (2027-2032) & (US$ Million) Table 14. Global Sunitinib Generics Sales Market Share in Value by Type (2027-2032) Table 15. Global Sunitinib Generics Price by Type (2027-2032) & (US$/Unit) Table 16. North America Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 17. North America Sunitinib Generics Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 19. Europe Sunitinib Generics Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Sunitinib Generics Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 23. Latin America Sunitinib Generics Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Sunitinib Generics Sales by Type (2021-2026) & (US$ Million) Table 26. Sunitinib Generics Industry Trends Table 27. Sunitinib Generics Industry Drivers Table 28. Sunitinib Generics Industry Opportunities and Challenges Table 29. Sunitinib Generics Industry Restraints Table 30. Global Sunitinib Generics Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Sunitinib Generics Revenue Market Share by Company (2021-2026) Table 32. Global Sunitinib Generics Sales by Company (2021-2026) & (K Units) Table 33. Global Sunitinib Generics Sales Share by Company (2021-2026) Table 34. Global Sunitinib Generics Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Sunitinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Sunitinib Generics Major Company Production Sites and Headquarters Table 37. Global Sunitinib Generics Company, Product Type & Application Table 38. Global Sunitinib Generics Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Sunitinib Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Sunitinib Generics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Sunitinib Generics Sales by Region (2021-2026) & (K Units) Table 43. Global Sunitinib Generics Sales Market Share in Volume by Region (2021-2026) Table 44. Global Sunitinib Generics Sales by Region (2021-2026) & (US$ Million) Table 45. Global Sunitinib Generics Sales Market Share in Value by Region (2021-2026) Table 46. Global Sunitinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Sunitinib Generics Sales by Region (2027-2032) & (K Units) Table 48. Global Sunitinib Generics Sales Market Share in Volume by Region (2027-2032) Table 49. Global Sunitinib Generics Sales by Region (2027-2032) & (US$ Million) Table 50. Global Sunitinib Generics Sales Market Share in Value by Region (2027-2032) Table 51. Global Sunitinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Sunitinib Generics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 54. Global Sunitinib Generics Sales Market Share in Volume by Application (2021-2026) Table 55. Global Sunitinib Generics Sales by Application (2021-2026) & (US$ Million) Table 56. Global Sunitinib Generics Sales Market Share in Value by Application (2021-2026) Table 57. Global Sunitinib Generics Price by Application (2021-2026) & (US$/Unit) Table 58. Global Sunitinib Generics Sales by Application (2027-2032) & (K Units) Table 59. Global Sunitinib Generics Sales Market Share in Volume by Application (2027-2032) Table 60. Global Sunitinib Generics Sales by Application (2027-2032) & (US$ Million) Table 61. Global Sunitinib Generics Sales Market Share in Value by Application (2027-2032) Table 62. Global Sunitinib Generics Price by Application (2027-2032) & (US$/Unit) Table 63. North America Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 64. North America Sunitinib Generics Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 66. Europe Sunitinib Generics Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Sunitinib Generics Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 70. Latin America Sunitinib Generics Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Sunitinib Generics Sales by Application (2021-2026) & (US$ Million) Table 73. Aprazer Healthcare Company Information Table 74. Aprazer Healthcare Business Overview Table 75. Aprazer Healthcare Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Aprazer Healthcare Sunitinib Generics Product Portfolio Table 77. Aprazer Healthcare Recent Development Table 78. Taj Pharma Company Information Table 79. Taj Pharma Business Overview Table 80. Taj Pharma Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Taj Pharma Sunitinib Generics Product Portfolio Table 82. Taj Pharma Recent Development Table 83. Teva Company Information Table 84. Teva Business Overview Table 85. Teva Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Teva Sunitinib Generics Product Portfolio Table 87. Teva Recent Development Table 88. Zydus Company Information Table 89. Zydus Business Overview Table 90. Zydus Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Zydus Sunitinib Generics Product Portfolio Table 92. Zydus Recent Development Table 93. Hansoh Pharma Company Information Table 94. Hansoh Pharma Business Overview Table 95. Hansoh Pharma Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hansoh Pharma Sunitinib Generics Product Portfolio Table 97. Hansoh Pharma Recent Development Table 98. Hunan Kelun Pharmaceutical Company Information Table 99. Hunan Kelun Pharmaceutical Business Overview Table 100. Hunan Kelun Pharmaceutical Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hunan Kelun Pharmaceutical Sunitinib Generics Product Portfolio Table 102. Hunan Kelun Pharmaceutical Recent Development Table 103. Qilu Pharmaceutical Company Information Table 104. Qilu Pharmaceutical Business Overview Table 105. Qilu Pharmaceutical Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Qilu Pharmaceutical Sunitinib Generics Product Portfolio Table 107. Qilu Pharmaceutical Recent Development Table 108. CSPC Pharmaceutical Company Information Table 109. CSPC Pharmaceutical Business Overview Table 110. CSPC Pharmaceutical Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. CSPC Pharmaceutical Sunitinib Generics Product Portfolio Table 112. CSPC Pharmaceutical Recent Development Table 113. Chia Tai Tianqing Company Information Table 114. Chia Tai Tianqing Business Overview Table 115. Chia Tai Tianqing Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Chia Tai Tianqing Sunitinib Generics Product Portfolio Table 117. Chia Tai Tianqing Recent Development Table 118. North America Sunitinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 120. North America Sunitinib Generics Sales Market Share by Country (2021-2026) Table 121. North America Sunitinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Sunitinib Generics Sales Market Share Forecast by Country (2027-2032) Table 123. North America Sunitinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Sunitinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Sunitinib Generics Market Share by Country (2021-2026) Table 126. North America Sunitinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Sunitinib Generics Market Share Forecast by Country (2027-2032) Table 128. Europe Sunitinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 130. Europe Sunitinib Generics Sales Market Share by Country (2021-2026) Table 131. Europe Sunitinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Sunitinib Generics Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Sunitinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Sunitinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Sunitinib Generics Market Share by Country (2021-2026) Table 136. Europe Sunitinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Sunitinib Generics Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Sunitinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Sunitinib Generics Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Sunitinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Sunitinib Generics Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Sunitinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Sunitinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Sunitinib Generics Market Share by Country (2021-2026) Table 146. Asia-Pacific Sunitinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Sunitinib Generics Market Share Forecast by Country (2027-2032) Table 148. Latin America Sunitinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 150. Latin America Sunitinib Generics Sales Market Share by Country (2021-2026) Table 151. Latin America Sunitinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Sunitinib Generics Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Sunitinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Sunitinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Sunitinib Generics Market Share by Country (2021-2026) Table 156. Latin America Sunitinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Sunitinib Generics Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Sunitinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Sunitinib Generics Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Sunitinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Sunitinib Generics Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Sunitinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Sunitinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Sunitinib Generics Market Share by Country (2021-2026) Table 166. Middle East and Africa Sunitinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Sunitinib Generics Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Sunitinib Generics Distributors List Table 171. Sunitinib Generics Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Sunitinib Generics Image Figure 2. Global Sunitinib Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sunitinib Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Sunitinib Generics Sales (2021-2032) & (K Units) Figure 5. 50mg per Unit Image Figure 6. Global 50mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 7. 37.5mg per Unit Image Figure 8. Global 37.5mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 9. 20mg per Unit Image Figure 10. Global 20mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 11. 12.5mg per Unit Image Figure 12. Global 12.5mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Sunitinib Generics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Sunitinib Generics Market Share by Type 2025 VS 2032 Figure 15. North America Sunitinib Generics Sales Market Share in Volume by Type in 2025 Figure 16. North America Sunitinib Generics Sales Market Share in Value by Type in 2025 Figure 17. Europe Sunitinib Generics Sales Market Share in Volume by Type in 2025 Figure 18. Europe Sunitinib Generics Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Sunitinib Generics Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Sunitinib Generics Sales Market Share in Value by Type in 2025 Figure 21. Latin America Sunitinib Generics Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Sunitinib Generics Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Sunitinib Generics Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Sunitinib Generics Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Sunitinib Generics Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pancreatic Neuroendocrine Tumors Image Figure 28. Global Pancreatic Neuroendocrine Tumors Sales YoY Growth (2021-2032) & (K Units) Figure 29. Gastrointestinal Stromal Tumors Image Figure 30. Global Gastrointestinal Stromal Tumors Sales YoY Growth (2021-2032) & (K Units) Figure 31. Renal cell Carcinoma Image Figure 32. Global Renal cell Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Sunitinib Generics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Sunitinib Generics Market Share by Application 2025 VS 2032 Figure 37. North America Sunitinib Generics Sales Market Share in Volume by Application in 2025 Figure 38. North America Sunitinib Generics Sales Market Share in Value by Application in 2025 Figure 39. Europe Sunitinib Generics Sales Market Share in Volume by Application in 2025 Figure 40. Europe Sunitinib Generics Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Sunitinib Generics Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Sunitinib Generics Sales Market Share in Value by Application in 2025 Figure 43. Latin America Sunitinib Generics Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Sunitinib Generics Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Sunitinib Generics Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Sunitinib Generics Sales Market Share in Value by Application in 2025 Figure 47. North America Sunitinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Sunitinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Sunitinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Sunitinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Sunitinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Sunitinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Sunitinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Sunitinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Sunitinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Sunitinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Sunitinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Sunitinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Sunitinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Sunitinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Sunitinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Sunitinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Sunitinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Sunitinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Sunitinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Sunitinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Sunitinib Generics Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Sunitinib Generics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg per Unit
  • 37.5mg per Unit
  • 20mg per Unit
  • 12.5mg per Unit
Applications
  • Pancreatic Neuroendocrine Tumors
  • Gastrointestinal Stromal Tumors
  • Renal cell Carcinoma
  • Other
Companies covered
  • Aprazer Healthcare
  • Taj Pharma
  • Teva
  • Zydus
  • Hansoh Pharma
  • Hunan Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • CSPC Pharmaceutical
  • Chia Tai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sunitinib Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sunitinib Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sunitinib Generics Market by Type
  6. 1.3.1 50mg per Unit
  7. 1.3.2 37.5mg per Unit
  8. 1.3.3 20mg per Unit
  9. 1.3.4 12.5mg per Unit
  10. 1.4 Global Sunitinib Generics Market Size by Type
  11. 1.4.1 Global Sunitinib Generics Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Sunitinib Generics Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Sunitinib Generics Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Sunitinib Generics Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Sunitinib Generics Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Sunitinib Generics Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Sunitinib Generics Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Sunitinib Generics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sunitinib Generics Industry Trends
  2. 2.2 Sunitinib Generics Industry Drivers
  3. 2.3 Sunitinib Generics Industry Opportunities and Challenges
  4. 2.4 Sunitinib Generics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sunitinib Generics Revenue (2021-2026)
  2. 3.2 Global Top Players by Sunitinib Generics Sales (2021-2026)
  3. 3.3 Global Top Players by Sunitinib Generics Price (2021-2026)
  4. 3.4 Global Sunitinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sunitinib Generics Major Company Production Sites & Headquarters
  6. 3.6 Global Sunitinib Generics Company, Product Type & Application
  7. 3.7 Global Sunitinib Generics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sunitinib Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sunitinib Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sunitinib Generics Tier 1, Tier 2, and Tier 3
4 Sunitinib Generics Regional Status and Outlook
  1. 4.1 Global Sunitinib Generics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sunitinib Generics Historic Market Size by Region
  3. 4.2.1 Global Sunitinib Generics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sunitinib Generics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sunitinib Generics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sunitinib Generics Forecasted Market Size by Region
  7. 4.3.1 Global Sunitinib Generics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sunitinib Generics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sunitinib Generics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sunitinib Generics by Application
  1. 5.1 Sunitinib Generics Market by Application
  2. 5.1.1 Pancreatic Neuroendocrine Tumors
  3. 5.1.2 Gastrointestinal Stromal Tumors
  4. 5.1.3 Renal cell Carcinoma
  5. 5.1.4 Other
  6. 5.2 Global Sunitinib Generics Market Size by Application
  7. 5.2.1 Global Sunitinib Generics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Sunitinib Generics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Sunitinib Generics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Sunitinib Generics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Sunitinib Generics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Sunitinib Generics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Sunitinib Generics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Sunitinib Generics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aprazer Healthcare
  2. 6.1.1 Aprazer Healthcare Company Information
  3. 6.1.2 Aprazer Healthcare Business Overview
  4. 6.1.3 Aprazer Healthcare Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aprazer Healthcare Sunitinib Generics Product Portfolio
  6. 6.1.5 Aprazer Healthcare Recent Developments
  7. 6.2 Taj Pharma
  8. 6.2.1 Taj Pharma Company Information
  9. 6.2.2 Taj Pharma Business Overview
  10. 6.2.3 Taj Pharma Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taj Pharma Sunitinib Generics Product Portfolio
  12. 6.2.5 Taj Pharma Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Sunitinib Generics Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Zydus
  20. 6.4.1 Zydus Company Information
  21. 6.4.2 Zydus Business Overview
  22. 6.4.3 Zydus Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Sunitinib Generics Product Portfolio
  24. 6.4.5 Zydus Recent Developments
  25. 6.5 Hansoh Pharma
  26. 6.5.1 Hansoh Pharma Company Information
  27. 6.5.2 Hansoh Pharma Business Overview
  28. 6.5.3 Hansoh Pharma Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hansoh Pharma Sunitinib Generics Product Portfolio
  30. 6.5.5 Hansoh Pharma Recent Developments
  31. 6.6 Hunan Kelun Pharmaceutical
  32. 6.6.1 Hunan Kelun Pharmaceutical Company Information
  33. 6.6.2 Hunan Kelun Pharmaceutical Business Overview
  34. 6.6.3 Hunan Kelun Pharmaceutical Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hunan Kelun Pharmaceutical Sunitinib Generics Product Portfolio
  36. 6.6.5 Hunan Kelun Pharmaceutical Recent Developments
  37. 6.7 Qilu Pharmaceutical
  38. 6.7.1 Qilu Pharmaceutical Company Information
  39. 6.7.2 Qilu Pharmaceutical Business Overview
  40. 6.7.3 Qilu Pharmaceutical Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qilu Pharmaceutical Sunitinib Generics Product Portfolio
  42. 6.7.5 Qilu Pharmaceutical Recent Developments
  43. 6.8 CSPC Pharmaceutical
  44. 6.8.1 CSPC Pharmaceutical Company Information
  45. 6.8.2 CSPC Pharmaceutical Business Overview
  46. 6.8.3 CSPC Pharmaceutical Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSPC Pharmaceutical Sunitinib Generics Product Portfolio
  48. 6.8.5 CSPC Pharmaceutical Recent Developments
  49. 6.9 Chia Tai Tianqing
  50. 6.9.1 Chia Tai Tianqing Company Information
  51. 6.9.2 Chia Tai Tianqing Business Overview
  52. 6.9.3 Chia Tai Tianqing Sunitinib Generics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chia Tai Tianqing Sunitinib Generics Product Portfolio
  54. 6.9.5 Chia Tai Tianqing Recent Developments
7 North America by Country
  1. 7.1 North America Sunitinib Generics Sales by Country
  2. 7.1.1 North America Sunitinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sunitinib Generics Sales by Country (2021-2026)
  4. 7.1.3 North America Sunitinib Generics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sunitinib Generics Market Size by Country
  6. 7.2.1 North America Sunitinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sunitinib Generics Market Size by Country (2021-2026)
  8. 7.2.3 North America Sunitinib Generics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sunitinib Generics Sales by Country
  2. 8.1.1 Europe Sunitinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sunitinib Generics Sales by Country (2021-2026)
  4. 8.1.3 Europe Sunitinib Generics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sunitinib Generics Market Size by Country
  6. 8.2.1 Europe Sunitinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sunitinib Generics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sunitinib Generics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sunitinib Generics Sales by Country
  2. 9.1.1 Asia-Pacific Sunitinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sunitinib Generics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sunitinib Generics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sunitinib Generics Market Size by Country
  6. 9.2.1 Asia-Pacific Sunitinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sunitinib Generics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sunitinib Generics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sunitinib Generics Sales by Country
  2. 10.1.1 South America Sunitinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sunitinib Generics Sales by Country (2021-2026)
  4. 10.1.3 South America Sunitinib Generics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sunitinib Generics Market Size by Country
  6. 10.2.1 South America Sunitinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sunitinib Generics Market Size by Country (2021-2026)
  8. 10.2.3 South America Sunitinib Generics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sunitinib Generics Sales by Country
  2. 11.1.1 Middle East and Africa Sunitinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sunitinib Generics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sunitinib Generics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sunitinib Generics Market Size by Country
  6. 11.2.1 Middle East and Africa Sunitinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sunitinib Generics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sunitinib Generics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sunitinib Generics Value Chain Analysis
  2. 12.1.1 Sunitinib Generics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sunitinib Generics Production Mode & Process
  7. 12.2 Sunitinib Generics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sunitinib Generics Distributors
  10. 12.2.3 Sunitinib Generics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst